Molecular%20Mechanisms%20of%20Pharmacological%20Action
Showing 26 - 50 of >10,000
Phenotyping Disease Severity in Asthma
Recruiting
- Asthma
- Bronchoscopy
-
Calgary, Alberta, CanadaUniversity of Calgary
May 18, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)
Not yet recruiting
- Diabetes Mellitus
- +4 more
- DWP16001
- Dapagliflozin Tablet
- (no location specified)
Aug 16, 2022
Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)
Not yet recruiting
- Basic Science
- Lysergic Acid Diethylamide Tartrate
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Jul 11, 2023
Testicular Tumors, Tumors, Germ Cell and Embryonal, Tumors Trial in Bratislava (Avelumab)
Completed
- Testicular Neoplasms
- +6 more
-
Bratislava, SlovakiaNational Cancer Institute
Mar 3, 2019
Xeljanz (Registered) in Ulcerative Colitis Patients
Completed
- Ulcerative Colitis
- Non-intervention
-
Seoul, Korea, Republic ofPfizer
Nov 16, 2022
Post-Traumatic Stress Disorders, MDD Trial in Minneapolis (Ketamine, Normal Saline)
Recruiting
- Post-Traumatic Stress Disorders
- Major Depressive Disorder
- Ketamine
- Normal Saline
-
Minneapolis, MinnesotaMinneapolis Veterans Affairs Health Care System
Jan 13, 2022
Migraine Without Aura Trial in Copenhagen (Riociguat (BAY 63-2521), Placebo)
Not yet recruiting
- Migraine Without Aura
- Riociguat (BAY 63-2521)
- Placebo
-
Copenhagen, Glostrup, DenmarkDanish Headache Center
Feb 20, 2023
Hereditary Transthyretin Amyloidosis Trial in Roma (Assessment of disease biomarkers)
Recruiting
- Hereditary Transthyretin Amyloidosis
- Assessment of disease biomarkers
-
Roma, ID, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Jun 26, 2023
Healthy Volunteer Trial in Prahran (Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI),
Completed
- Healthy Volunteer
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
- Vardenafil Oral Tablet
-
Prahran, Victoria, AustraliaNucleus Network, Burnet Institute
Nov 2, 2022
Drug-resistant Psychiatric Disorders Using Induced Pluripotent
Enrolling by invitation
- Depressive Disorder, Treatment-Resistant
-
Monza, Monza E Brianza, ItalyFondazione IRCCS San Gerardo di Monza
May 24, 2023
Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))
Recruiting
- Alpha1-Antitrypsin Deficiency
- Alpha-1 15%
- Liquid Alpha1-Proteinase Inhibitor (Human)
-
Gainesville, Florida
- +5 more
Jan 13, 2023
Fibromyalgia Trial in Kutahya (Manual Lymphatic Drainage, Medical treatment, Sham Manual Lymphatic Drainage)
Not yet recruiting
- Fibromyalgia
- Manual Lymphatic Drainage
- +2 more
-
Kutahya, TurkeyKutahya Health Sciences University Evliya Celebi Hospital
Jun 23, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
-
Cooperstown, New York
- +10 more
Dec 11, 2022
Ischemic Stroke Trial in Worldwide (Direct endovascular clot retrieval, Bridging thrombolysis followed by ECR)
Completed
- Ischemic Stroke
- Direct endovascular clot retrieval
- Bridging thrombolysis followed by ECR
-
Liverpool, New South Wales, Australia
- +32 more
Jun 14, 2022
Diabetic Patients, Type II Diabetes Trial in Sevilla (OA-enriched functional olive oil, commercial olive oil)
Recruiting
- Diabetic Patients
- Type II Diabetes Mellitus
- OA-enriched functional olive oil
- commercial olive oil
-
Sevilla, Andalicía, SpainVirgen del Rocío University Hospital
Sep 1, 2023
Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))
Not yet recruiting
- Hemophilia B
- CSL222 (AAV5-hFIXco-Padua)
- (no location specified)
Aug 14, 2023
Gastrointestinal Cancer Trial in Philadelphia (Pharmacogenetic test)
Recruiting
- Gastrointestinal Cancer
- Pharmacogenetic test
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 18, 2022
Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,
Active, not recruiting
- Adult Diffuse Large Cell Lymphoma
- +2 more
- DPX-Survivac
- +2 more
-
Calgary, Alberta, Canada
- +5 more
Nov 9, 2022
Pulmonary Arterial Hypertension Trial in Darlinghurst, Hobart, Melbourne (Drug: RT234 - vardenafil inhalation powder; Device:
Completed
- Pulmonary Arterial Hypertension
- Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS01 DPI)
-
Darlinghurst, New South Wales, Australia
- +2 more
Apr 20, 2022
Healthy Trial (Dabigatran etexilate (DE), Rosuvastatin, PF-07081532)
Not yet recruiting
- Healthy
- Dabigatran etexilate (DE)
- +2 more
- (no location specified)
Mar 15, 2023
Microbiome in Head and Neck Squamous Cell Carcinoma
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Metagenomic sequencing
- Metabolic analysis
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Apr 19, 2023